Achaogen COO Promoted to Top Post, Effective Jan. 1, 2018 Post author:Sam Post published:December 11, 2017 Post category:BioPharma Dr. Hillan will remain on, and Mr. Wise will join, the Company’s Board of Directors. Source: BioSpace You Might Also Like Biotech Pioneer Submits Regulation A+ Filing With For Up To $50 Million Initial Public Offering September 6, 2017 Cancer Biotech Novocure Scores New $150M Debt Financing February 7, 2018 Kedrion And Kamada Receive FDA Approval Of KEDRAB For Post-Exposure Prophylaxis Against Rabies Infection August 24, 2017
Biotech Pioneer Submits Regulation A+ Filing With For Up To $50 Million Initial Public Offering September 6, 2017
Kedrion And Kamada Receive FDA Approval Of KEDRAB For Post-Exposure Prophylaxis Against Rabies Infection August 24, 2017
